Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01944215 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 154
- Enrollment target
NCT01944215: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT01944215 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01944215, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 154 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine if exercise, fasting, or eating prior to the molecular breast imaging study will have an effect on the uptake of the tracer in the breast tissue.
Interventions
- OTHER Exercise
- DRUG Caffeine Tablet
- DIETARY_SUPPLEMENT Meal
- RADIATION Sestamibi
- OTHER External Heating
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01944215
The ClinicalTrials.gov registry entry for NCT01944215 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Exercise is the first listed.
NCT01944215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01944215 about?
NCT01944215 is a clinical study titled "Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue". The primary objective of this study is to determine if exercise, fasting, or eating prior to the molecular breast imaging study will have an effect on the uptake of the tracer in the breast tissue.
What is the current status of trial NCT01944215?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 154 participants. The study started on 2013-09. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01944215?
The interventions under investigation include: Exercise (OTHER), Caffeine Tablet (DRUG), Meal (DIETARY_SUPPLEMENT), Sestamibi (RADIATION), External Heating (OTHER).
Who is sponsoring clinical trial NCT01944215?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.